| 前收市價 | 7.80 |
| 開市 | 7.85 |
| 買盤 | 0.00 x 0 |
| 賣出價 | 0.00 x 0 |
| 今日波幅 | 7.81 - 7.86 |
| 52 週波幅 | 6.96 - 14.90 |
| 成交量 | |
| 平均成交量 | 2,040,490 |
| 市值 | 30.691B |
| Beta 值 (5 年，每月) | 0.97 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.80 |
| 業績公佈日 | 2024年5月14日 |
| 遠期股息及收益率 | 0.03 (0.38%) |
| 除息日 | 2024年4月29日 |
| 1 年預測目標價 | 28.89 |
ZacksRegeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Regeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.
- Reuters
UPDATE 1-Bayer's Monsanto wins reversal of $185 million PCBs verdict in Washington court
Monsanto spinoff Pharmacia, which sold now-banned chemicals called polychlorinated biphenyls (PCBs), was found liable in 2021. Three teachers claimed they suffered brain damage from PCBs that leaked from light fixtures at the Sky Valley Education Center (SVEC) in Monroe, Washington.
ReutersBayer's Monsanto wins reversal of $185 million PCBs verdict in Washington court
Monsanto spinoff Pharmacia, which sold now-banned chemicals called polychlorinated biphenyls (PCBs), was found liable in 2021. Three teachers claimed they suffered brain damage from PCBs that leaked from light fixtures at the Sky Valley Education Center (SVEC) in Monroe, Washington.
